Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,573 | 428 | 96.9% |
| Education | $304.51 | 5 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,810 | 83 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,301 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,090 | 61 | $0 (2024) |
| ITI, Inc. | $1,011 | 33 | $0 (2023) |
| Alkermes, Inc. | $950.28 | 50 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $711.43 | 21 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $484.69 | 17 | $0 (2024) |
| Lundbeck LLC | $450.26 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $317.27 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $316.27 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,780 | 152 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($711.43) |
| 2023 | $3,305 | 162 | ITI, Inc. ($550.04) |
| 2022 | $1,692 | 79 | ABBVIE INC. ($622.76) |
| 2021 | $441.29 | 22 | AbbVie Inc. ($153.28) |
| 2020 | $40.30 | 2 | Janssen Pharmaceuticals, Inc ($21.00) |
| 2019 | $359.14 | 10 | Janssen Pharmaceuticals, Inc ($197.12) |
| 2018 | $122.39 | 4 | Alkermes, Inc. ($100.59) |
| 2017 | $137.09 | 2 | Otsuka America Pharmaceutical, Inc. ($123.01) |
All Payment Transactions
433 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: CNS | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: CNS | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $84.23 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 98 | 391 | $76,000 | $24,771 |
| 2022 | 3 | 89 | 227 | $50,737 | $15,535 |
| 2021 | 3 | 49 | 101 | $27,039 | $7,899 |
| 2020 | 2 | 54 | 116 | $28,363 | $6,480 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 191 | $38,200 | $13,644 | 35.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 40 | 178 | $31,150 | $8,227 | 26.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 22 | $6,650 | $2,899 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 139 | $31,343 | $9,593 | 30.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 25 | 66 | $11,550 | $3,128 | 27.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 21 | 22 | $7,844 | $2,814 | 35.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 69 | $17,955 | $5,168 | 28.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 13 | 14 | $4,872 | $2,047 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 18 | $4,212 | $682.80 | 16.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 53 | $13,621 | $3,268 | 24.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 63 | $14,742 | $3,212 | 21.8% |
About Brian Ackerman
Brian Ackerman is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1235517913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Ackerman has received a total of $9,878 in payments from pharmaceutical and medical device companies, with $3,780 received in 2024. These payments were reported across 433 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($9,573).
As a Medicare-enrolled provider, Ackerman has provided services to 290 Medicare beneficiaries, totaling 835 services with total Medicare billing of $54,684. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Providence, RI
- Active Since 05/13/2015
- Last Updated 08/06/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235517913
Products in Payments
- VRAYLAR (Drug) $1,810
- CAPLYTA (Drug) $1,722
- REXULTI (Drug) $1,247
- ARISTADA (Drug) $804.74
- INGREZZA (Drug) $484.69
- Austedo XR (Drug) $379.08
- AUSTEDO (Drug) $323.92
- FANAPT (Drug) $316.27
- TRINTELLIX (Drug) $278.39
- INVEGA SUSTENNA (Drug) $229.94
- NUEDEXTA (Drug) $220.61
- Auvelity (Drug) $216.98
- LATUDA (Drug) $198.54
- JORNAY PM (Drug) $193.69
- UZEDY (Drug) $184.48
- QUVIVIQ (Drug) $155.91
- ABILIFY MAINTENA (Drug) $146.63
- COBENFY (Drug) $126.28
- ABILIFY ASIMTUFII (Drug) $119.57
- Azstarys (Drug) $94.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Dr. James Greer, Md, MD
Psychiatry — Payments: $727,742
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Kazi Salahuddin, Md, MD
Psychiatry — Payments: $4,840
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723
Dr. Timothy Mariano, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $4,409